Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo

Journal of Neuroscience

Volumn 35, Issue 10, 2015, Pages 4332-4349

  Peterson, Sheri L ^a,b,c   Nguyen, Hal X ^a,b   Mendez, Oscar A ^a,b   Anderson, Aileen J ^a,b,c  

^a Sue and Bill Gross Stem Cell Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C1q; Complement; Inflammation; Regeneration; Spinal cord injury; Sprouting

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; COMPLEMENT COMPONENT C1Q; CYCLIC AMP; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; NEUROMODULIN; PROTEOLIPID PROTEIN; ARG1 PROTEIN, MOUSE; ARGINASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CAMP ASSAY; CELL SURVIVAL; FEMALE; GENE EXPRESSION; GRAY MATTER; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; INFLAMMATION; MALE; MYELINATION; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE SPROUTING; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PYRAMIDAL TRACT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE INJURY; SIGNAL TRANSDUCTION; SPINAL CORD AXON REGENERATION; SPINAL CORD INJURY; SPINAL GANGLION; WESTERN BLOTTING; ANIMAL; AXON; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; METABOLISM; MOUSE; MYELIN SHEATH; NERVE CELL; NERVE REGENERATION; NEURITE; PATHOLOGY; PHYSIOLOGY; SCIATIC NEUROPATHY; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ANIMALS; ARGINASE; AXONS; CELLS, CULTURED; COMPLEMENT C1Q; CYCLIC AMP; DISEASE MODELS, ANIMAL; FEMALE; GANGLIA, SPINAL; GAP-43 PROTEIN; GENE EXPRESSION REGULATION; IN VITRO TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE REGENERATION; NEURITES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NEUROPATHY; SPINAL CORD INJURIES;

EID: 84924454814     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4473-12.2015     Document Type: Article

References (94)

1. Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ (1996) Localization and cell association of C1q in Alzheimer’s disease brain. Exp Neu-rol 138:22–32.
2. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271:20246–20249.
3. Anderson AJ, Robert S, Huang W, Young W, Cotman CW (2004) Activa-tionof complement pathways after contusion-induced spinal cord injury. J Neurotrauma 21:1831–1846.
4. Bagamery K, Kvell K, Landau R, Graham J (2005) Flow cytometric analysis of CD41-labeled platelets isolated by the rapid, one-step OptiPrep method from human blood. Cytometry A 65:84–87.
5. Bareyre FM, Haudenschild B, Schwab ME (2002) Long-lasting sprouting and gene expression changes inducedby the monoclonal antibody IN-1 in the adult spinal cord. J Neurosci 22:7097–7110.
6. Bartsch U, Bandtlow CE, Schnell L, Bartsch S, Spillmann AA, Rubin BP, Hillenbrand R, Montag D, Schwab ME, Schachner M (1995) Lack of evidence that myelin-associated glycoprotein is a major inhibitor of ax-onal regeneration in the CNS. Neuron 15:1375–1381.
7. Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ (2010) Quantitative analysisofcellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 133:433–447.
8. Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ (2013) C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-beta neurotoxicity. J Biol Chem 288:654–665.
9. Benowitz LI, Popovich PG (2011) Inflammation and axon regeneration. Curr Opin Neurol 24:577–583.
10. Berg A, Zelano J, Stephan A, Thams S, Barres BA, Pekny M, Pekna M, Cull-heim S (2012) Reduced removal of synaptic terminals from axotomized spinal motoneurons in the absence of complement C3. Exp Neurol 237: 8–17.
11. Borges LF, Iversen SD (1986) Topography of choline acetyltransferase immu-noreactive neurons and fibers in the rat spinal cord. Brain Res 362:140–148.
12. Botto M (1998) C1q knock-out mice for the study of complement deficiency in autoimmune disease. Exp Clin Immunogenet 15:231–234.
13. Brück W, Friede RL (1991) The role of complement in myelin phagocytosis during PNS wallerian degeneration. J Neurol Sci 103:182–187.
14. Cafferty WB, McGee AW, Strittmatter SM (2008) Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci 31:215–220.
15. Cafferty WB, Duffy P, Huebner E, Strittmatter SM (2010) MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci 30:6825–6837.
16. Cai D, Shen Y, De Bellard M, Tang S, Filbin MT (1999) Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and my-elin via a cAMP-dependent mechanism. Neuron 22:89–101.
17. Caroni P, Schwab ME (1988) Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibro-blast spreading. J Cell Biol 106:1281–1288.
18. Chaudhry N, Filbin MT (2007) Myelin-associated inhibitory signaling and strategies to overcome inhibition. J Cereb Blood Flow Metab 27:1096–1107.
19. Chu Y, Jin X, Parada I, Pesic A, Stevens B, Barres B, Prince DA (2010) Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proc Natl Acad Sci U S A 107:7975–7980.
20. Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, Yang AJ (2006) Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J Biol Chem 281:10825–10838.
21. Del Rio-Tsonis K, Tsonis PA, Zarkadis IK, Tsagas AG, Lambris JD (1998) Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles. J Immunol 161:6819–6824.
22. Deng K, He H, Qiu J, Lorber B, Bryson JB, Filbin MT (2009) Increased synthesis of spermidine as a result of upregulation of arginase I promotes axonal regeneration in culture and in vivo. J Neurosci 29:9545–9552.
23. Duce JA, Hollander W, Jaffe R, Abraham CR (2006) Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain. Neurobiol Aging 27:633–644.
24. Gadjeva MG, Rouseva MM, Zlatarova AS, Reid KB, Kishore U, Kojouharova MS (2008) Interaction of human C1q with IgG and IgM: revisited. Biochemistry 47:13093–13102.
25. Galvan MD, Luchetti S, Burgos AM, Nguyen HX, Hooshmand MJ, Hamers FP, Anderson AJ (2008) Deficiency in complement C1q improves his-tological and functional locomotor outcome after spinal cord injury. J Neurosci 28:13876–13888.
26. Greer JM, Lees MB (2002) Myelin proteolipid protein–the first 50 years. Int J Biochem Cell Biol 34:211–215.
27. Guo Q, Li S, Liang Y, Zhang Y, Zhang J, Wen C, Lin S, Wang H, Su B (2010) Effects of C3 deficiency on inflammation and regeneration following spinal cord injury in mice. Neurosci Lett 485:32–36.
28. Harauz G, Ladizhansky V, Boggs JM (2009) Structural polymorphism and multifunctionality of myelin basic protein. Biochemistry 48:8094–8104.
29. Haynes T, Luz-Madrigal A, Reis ES, Echeverri Ruiz NP, Grajales-Esquivel E, Tzekou A, Tsonis PA, Lambris JD, Del Rio-Tsonis K (2013) Complement anaphylatoxin C3a is a potent inducer of embryonic chick retina regeneration. Nat Commun 4:2312.
30. Henley JR, Huang KH, Wang D, Poo MM (2004) Calcium mediates bidirectional growth cone turning induced by myelin-associated glycopro-tein. Neuron 44:909–916.
31. Hines JH, Abu-Rub M, Henley JR (2010) Asymmetric endocytosis and remodeling of beta1-integrin adhesions during growth cone chemorepul-sion by MAG. Nat Neurosci 13:829–837.
32. Janeway C, ed (2001) Immunobiology, Ed 5. New York: Garland Publishing.
33. Johns TG, Bernard CC (1997) Binding of complement component Clq to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol Immunol 34:33–38.
34. Jones TB, McDaniel EE, Popovich PG (2005) Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 11:1223–1236.
35. Kim JE, Li S, GrandPre´ T, Qiu D, Strittmatter SM (2003) Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 38:187–199.
36. Kimura Y, Madhavan M, Call MK, Santiago W, Tsonis PA, Lambris JD, Del Rio-Tsonis K (2003) Expression of complement 3 and complement 5 in newt limb and lens regeneration. J Immunol 170:2331–2339.
37. Kirschfink M, Blase L, Engelmann S, Schwartz-Albiez R (1997) Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. J Immunol 158:1324–1331.
38. Kishore U, Gaboriaud C, Waters P, Shrive AK, Greenhough TJ, Reid KB, Sim RB, Arlaud GJ (2004) C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol 25:551–561.
39. Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A (1997) Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7:345–355.
40. Krumdieck R, Höök M, Rosenberg LC, Volanakis JE (1992) The proteogly-can decorin binds C1q and inhibits the activity of the C1 complex. J Immunol 149:3695–3701.
41. Lange PS, Langley B, Lu P, Ratan RR (2004) Novel roles for arginase in cell survival, regeneration, and translation in the central nervous system. J Nutr 134:2812S–2817S; discussion 2818S–2819S.
42. Lee JK, Geoffroy CG, Chan AF, Tolentino KE, Crawford MJ, Leal MA, Kang B, Zheng B (2010) Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 66:663–670.
43. Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I, Tedeschi A, Park KK, Jin D, Cai B, Xu B, Connolly L, Steward O, Zheng B, He Z (2010) PTEN deletion enhances the regenerative ability of adult cortico-spinal neurons. Nat Neurosci 13:1075–1081.
44. Loers G, Aboul-Enein F, Bartsch U, Lassmann H, Schachner M (2004) Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study. Mol Cell Neurosci 27:175–189.
45. Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA, Lambris JD (2001) A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol 166: 2479–2486.
46. McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A (2006) Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol 176:2950–2957.
47. McGreal E, Gasque P (2002) Structure-function studies of the receptors for complement C1q. Biochem Soc Trans 30:1010–1014.
48. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE (1994) Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13:805–811.
49. Mukherjee P, Pasinetti GM (2001) Complement anaphylatoxin C5a neuro-protects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem 77:43–49.
50. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT (1994) A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13:757–767.
51. Nauta AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, Gingras AR, Tzima S, Vivanco F, Egido J, Tijsma O, Hack EC, Daha MR, Roos A (2003) Biochemical and functional characterization ofthe interaction between pentraxin 3 and C1q. Eur J Immunol 33:465–473.
52. Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ (1997) cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6:119–129.
53. Neumann S, Bradke F, Tessier-Lavigne M, Basbaum AI (2002) Regeneration of sensory axons within the injured spinal cord induced by intragan-glionic cAMP elevation. Neuron 34:885–893.
54. Neumann S, Skinner K, Basbaum AI (2005) Sustaining intrinsic growth capacity of adult neurons promotes spinal cord regeneration. Proc Natl Acad Sci U S A 102:16848–16852.
55. Nguyen HX, Galvan MD, Anderson AJ (2008) Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury. J Neuroinflammation 5:26.
56. Nguyen T, Mehta NR, Conant K, Kim KJ, Jones M, Calabresi PA, Melli G, Hoke A, Schnaar RL, Ming GL, Song H, Keswani SC, Griffin JW (2009) Axonal protective effects of the myelin-associated glycoprotein. J Neuro-sci 29:630–637.
57. Niclou SP, Ehlert EM, Verhaagen J (2006) Chemorepellent axon guidance molecules in spinal cord injury. J Neurotrauma 23:409–421.
58. Osaka H, Mukherjee P, Aisen PS, Pasinetti GM (1999) Complement-derived anaphylatoxin C5a protects against glutamate-mediated neuro-toxicity. J Cell Biochem 73:303–311.
59. Patel SP, Sullivan PG, Lyttle TS, Magnuson DSK, Rabchevsky AG (2012) Acetyl-L-Carnitine treatment following spinal cord injury improves mi-tochondrial function correlated with remarkable tissue sparing and functional recovery. Neuroscience 210:296–307.
60. Peterson SL, Anderson AJ (2014) Complement and spinal cord injury: traditional and non-traditional aspects of complement cascade function in the injured spinal cord microenvironment. Exp Neurol 258:35–47.
61. Qiao F, Atkinson C, Song H, Pannu R, Singh I, Tomlinson S (2006) Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma. Am J Pathol 169:1039–1047.
62. Qiao F, Atkinson C, Kindy MS, Shunmugavel A, Morgan BP, Song H, Tom-linson S (2010) The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury. AmJPathol 177:3061–3070.
63. Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, Nilsson AK, Zwirner J, Wetsel RA, Gerard C, Pekny M, Pekna M (2006) Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 25:1364–1374.
64. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I (1992) Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 89:10016–10020.
65. Rosenzweig ES, Courtine G, Jindrich DL, Brock JH, Ferguson AR, Strand SC, Nout YS, Roy RR, Miller DM, Beattie MS, Havton LA, Bresnahan JC, Edgerton VR, Tuszynski MH (2010) Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury. Nat Neurosci 13:1505–1510.
66. Roumenina LT, Ruseva MM, Zlatarova A, Ghai R, Kolev M, Olova N, Gadjeva M, Agrawal A, Bottazzi B, Mantovani A, Reid KB, Kishore U, Kojou-harova MS (2006) Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A–C Chains. Biochemistry 45:4093–4104.
67. Sahu A, Lambris JD (2001) Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180:35–48.
68. Sandvig A, Berry M, Barrett LB, Butt A, Logan A (2004) Myelin-, reactive glia- and scar- derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46:225–251.
69. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B (2012) Micro-glia sculpt postnatal neural circuits in n activity and complement-dependent manner. Neuron 74:691–705.
70. Schnell L, Schwab ME (1990) Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343:269–272.
71. Schnell L, Hunanyan AS, Bowers WJ, Horner PJ, Federoff HJ, Gullo M, Schwab ME, Mendell LM, Arvanian VL (2011) Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional ‘detour’ in the hemisected spinal cord. Eur J Neurosci 34:1256–1267.
72. Schwab ME, Bartholdi D (1996) Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76:319–370.
73. Shinjyo N, Ståhlberg A, Dragunow M, Pekny M, Pekna M (2009) Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells 27:2824–2832.
74. Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neu-rosci 5:146–156.
75. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B, Christ F, Sansig G, van der Putten H, Schwab ME (2003) Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 38:201– 211.
76. Soares S, Barnat M, Salim C, von Boxberg Y, Ravailee-Veron M, Nothias F (2007) Extensive structural remodeling on the injured spinal cord revealed by phosphorylated MAP1B in sprouting axons and degenerating neurons. Eur J Neurosci 26:1446–1461.
77. Song H, Ming G, He Z, Lehmann M, McKerracher L, Tessier-Lavigne M, Poo M (1998) Conversion of neuronal growth cone responses from repul-sion to attraction by cyclic nucleotides. Science 281:1515–1518.
78. Spagnol G, Williams M, Srinivasan J, Golier J, Bauer D, Lebo RV, Latov N (1989) Molecular cloning of human myelin-associated glycoprotein. J Neurosci Res 24:137–142.
79. Starkey ML, Bleul C, Maier IC, Schwab ME (2011) Rehabilitative training following unilateral pyramidotomy in adult rats improves forelimb func-tionin anon-task-specific way. Exp Neurol 232:81–89.
80. Steward O, Sharp K, Yee KM, Hofstadter M (2008) A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp Neurol 209:446–468.
81. Sun X, Wang X, Chen T, Li T, Cao K, Lu A, Chen Y, Sun D, Luo J, Fan J, Young W, Ren Y (2010) Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system. PLoS One 5:e9380.
82. Tissot B, Daniel R, Place C (2003) Interaction of the C1 complex of complement with sulfated polysaccharide and DNA probed by single molecule fluorescence microscopy. Eur J Biochem 270:4714–4720.
83. Van Schravendijk MR, Dwek RA (1982) Interaction of C1q with DNA. Mol Immunol 19:1179–1187.
84. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z (2002) Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417:941–944.
85. Wanner IB, Anderson MA, Song B, Levine J, Fernandez A, Gray-Thompson Z, Ao Y, Sofroniew MV (2013) Glial scar borders are formed by newly proliferated, elongated astrocytes that interactto corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci 33:12870–12886.
86. Watson C, Paxinos G, Kayalioglu G (2009) The Spinal Cord: A Christopher and Dana Reeve Foundation Text and Atlas: Elsevier Science.
87. Weiss MD, Luciano CA, Quarles RH (2001) Nerve conduction abnormalities in aging mice deficient for myelin-associated glycoprotein. Muscle Nerve 24:1380–1387.
88. Woolf CJ, Reynolds ML, Molander C, O’Brien C, Lindsay RM, Benowitz LI (1990) The growth-associated protein GAP-43 appears in dorsal root ganglion cells and in the dorsal horn of the rat spinal cord following peripheral nerve injury. Neuroscience 34:465–478.
89. Wörter V, Schweigreiter R, Kinzel B, Mueller M, Barske C, Böck G, Frentzel S, Bandtlow CE (2009) Inhibitory activity of myelin-associated glycopro-tein on sensory neurons is largely independent of NgR1 and NgR2 and resides within Ig-Like domains 4 and 5. PLoS One 4:e5218.
90. Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease–a double-edged sword. Neuron 35:419–432.
91. Yang Y, Liu Y, Wei P, Peng H, Winger R, Hussain RZ, Ben LH, Cravens PD, Gocke AR, Puttaparthi K, Racke MK, McTigue DM, Lovett-Racke AE (2010) Silencing Nogo-A promotes functional recoveryindemyelinating disease. Ann Neurol 67:498–507.
92. Yin X, Crawford TO, Griffin JW, Tu Ph, Lee VM, Li C, Roder J, Trapp BD (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953–2015.
93. Yonemasu K, Kitajima H, Tanabe S, Ochi T, Shinkai H (1978) Effect of age on C1q and C3 levels in human serum and their presence in colostrum. Immunology 35:523–530.
94. Ziccardi RJ, Tschopp J (1982) The dissociation properties of native C1. Biochem Biophys Res Commun 107:618–623.